BIOMAT Database Logo BIOMAT Database Logo

An azole-resistant isolate of Malassezia pachydermatis. 2011

Misako Nijima, and Rui Kano, and Masahiko Nagata, and Atsuhiko Hasegawa, and Hiroshi Kamata
Department of Pathobiology, Nihon University School of Veterinary Medicine, 1866 Kameino, Fujisawa, Kanagawa 252-8510, Japan.

Canine Malassezia dermatitis (MD) is frequently treated with systemic ketoconazole (KTZ) and itaconazole (ITZ). However, the antifungal susceptibility of clinical isolates of M. pachydermatis from dogs and cats to the azoles has not been well investigated. In the present study, the in vitro susceptibility of the standard strain (CBS1879: the neotype strain of M. pachydermatis) and 29 clinical isolates of M. pachydermatis to the azoles was measured by a modified CLSI M27-A2 test using modified Dixon medium as well as by the E-test. The minimum inhibitory concentrations (MICs) of the 30 isolates of M. pachydermatis (including the neotype strain) against KTZ and ITZ were <0.03 μg/ml by the two methods. The MICs of 1 clinical isolate (ASC-11) were 1 and 2 μg/ml against KTZ, and 2 and 8 μg/ml against ITZ, by the modified CLSI M27-A2 test and the E-test, respectively. Thus, isolate ASC-11 may be resistant to these azoles, making this the first report of a resistant isolate of M. pachydermatis to KTZ and ITZ.

UI MeSH Term Description Entries
D007654 Ketoconazole Broad spectrum antifungal agent used for long periods at high doses, especially in immunosuppressed patients. Nizoral,R-41400,R41,400,R41400,R 41400
D008290 Malassezia A mitosporic fungal genus that causes a variety of skin disorders. Malassezia furfur (Pityrosporum orbiculare) causes TINEA VERSICOLOR. Pityrosporum,Pityrosporum ovale,Saccharomyces ovalis,Malassezia furfur,Pityrosporum orbiculare
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D002415 Cats The domestic cat, Felis catus, of the carnivore family FELIDAE, comprising over 30 different breeds. The domestic cat is descended primarily from the wild cat of Africa and extreme southwestern Asia. Though probably present in towns in Palestine as long ago as 7000 years, actual domestication occurred in Egypt about 4000 years ago. (From Walker's Mammals of the World, 6th ed, p801) Felis catus,Felis domesticus,Domestic Cats,Felis domestica,Felis sylvestris catus,Cat,Cat, Domestic,Cats, Domestic,Domestic Cat
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D017964 Itraconazole A triazole antifungal agent that inhibits cytochrome P-450-dependent enzymes required for ERGOSTEROL synthesis. Orungal,R-51211,Sporanox,R 51211,R51211
D025141 Drug Resistance, Fungal The ability of fungi to resist or to become tolerant to chemotherapeutic agents, antifungal agents, or antibiotics. This resistance may be acquired through gene mutation. Antibiotic Resistance, Fungal,Antifungal Drug Resistance,Resistance, Antifungal Drug

Related Publications

Misako Nijima, and Rui Kano, and Masahiko Nagata, and Atsuhiko Hasegawa, and Hiroshi Kamata
High multi-azole-resistant Malassezia pachydermatis clinical isolates from canine Malassezia dermatitis.
February 2020, Medical mycology,
Misako Nijima, and Rui Kano, and Masahiko Nagata, and Atsuhiko Hasegawa, and Hiroshi Kamata
Multi-azole-resistant strain of Malassezia pachydermatis isolated from a canine Malassezia dermatitis.
April 2019, Medical mycology,
Misako Nijima, and Rui Kano, and Masahiko Nagata, and Atsuhiko Hasegawa, and Hiroshi Kamata
Medium-chain fatty acid esters are effective even in azole-resistant Malassezia pachydermatis.
December 2022, Mycoses,
Misako Nijima, and Rui Kano, and Masahiko Nagata, and Atsuhiko Hasegawa, and Hiroshi Kamata
ERG11 Gene Variability and Azole Susceptibility in Malassezia pachydermatis.
April 2023, Mycopathologia,
Misako Nijima, and Rui Kano, and Masahiko Nagata, and Atsuhiko Hasegawa, and Hiroshi Kamata
Azole and terbinafine susceptibility testing of Malassezia pachydermatis in Japan.
March 2023, The Journal of veterinary medical science,
Misako Nijima, and Rui Kano, and Masahiko Nagata, and Atsuhiko Hasegawa, and Hiroshi Kamata
Azole susceptibility of Malassezia pachydermatis and Malassezia furfur and tentative epidemiological cut-off values.
September 2015, Medical mycology,
Misako Nijima, and Rui Kano, and Masahiko Nagata, and Atsuhiko Hasegawa, and Hiroshi Kamata
Azole resistance of Malassezia pachydermatis causing treatment failure in a dog.
March 2019, Medical mycology case reports,
Misako Nijima, and Rui Kano, and Masahiko Nagata, and Atsuhiko Hasegawa, and Hiroshi Kamata
In vitro activity of amphotericin B-azole combinations against Malassezia pachydermatis strains.
February 2019, Medical mycology,
Misako Nijima, and Rui Kano, and Masahiko Nagata, and Atsuhiko Hasegawa, and Hiroshi Kamata
Malassezia pachydermatis infections.
July 1998, The New England journal of medicine,
Misako Nijima, and Rui Kano, and Masahiko Nagata, and Atsuhiko Hasegawa, and Hiroshi Kamata
Malassezia pachydermatis infections.
July 1998, The New England journal of medicine,
Copied contents to your clipboard!